160
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Magnitude of Red Blood Cell Alloimmunization Among Pregnant Women Attending Antenatal Care at Wolaita Sodo University Comprehensive Specialized Hospital, Southwest Ethiopia

, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 663-669 | Received 23 Oct 2023, Accepted 21 Dec 2023, Published online: 22 Dec 2023

References

  • Mota MA. Red cell and human leukocyte antigen alloimmunization in candidates for renal transplantation: a reality.. Rev Bras Hematol Hemoter. 2013;35(3):160–161. doi:10.5581/1516-8484.20130046
  • Ngoma AM, Mutombo PB, Ikeda K, et al. Red blood cell alloimmunization in transfused patients in sub-Saharan Africa: a systematic review and meta-analysis. Transfus Apheresis Sci. 2016;54(2):296–302. doi:10.1016/j.transci.2015.10.017
  • Pahuja S, Gupta SK, Jain M, Pujani M. The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi. Blood Transfus. 2011;9(4):388. doi:10.2450/2011.0050-10
  • Gothwal M, Singh P, Bajpayee A, et al. Red cell alloimmunization in pregnancy: a study from a premier tertiary care centre of Western India. Obstet Gynecol Sci. 2023;66(2):84–93. doi:10.5468/ogs.22190
  • Cheesbrough MJUK. District Laboratory Practice in Tropical Countries, Part 1. 2 ed. Cambridge University Press; 2000.
  • Duplantie J, Gonzales OM, Bois A, et al. Cost-effectiveness of the management of rh-negative pregnant women. Obstet Gynaecol. 2013;35(8):730–740.
  • Osaro E, Charles AT. Rh isoimmunization in Sub-Saharan Africa indicates need for universal access to anti-RhD immunoglobulin and effective management of D-negative pregnancies. Int J Women’s Health. 2010;429–437. doi:10.2147/IJWH.S15165
  • Altuntas N, Yenicesu İ, Himmetoglu Ö, et al. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey. Transfus Apheresis Sci. 2013;48(3):377–380. doi:10.1016/j.transci.2013.04.021
  • Bricca P, Guinchard E, Bliem C. Management of feto-maternal red cell allo-immunizations. Transfus Clin Bio. 2011;18(2):269–276. doi:10.1016/j.tracli.2011.01.005
  • Urbaniak S, Greiss M. RhD haemolytic disease of the fetus and the newborn. Blood Rev. 2000;14(1):44–61. doi:10.1054/blre.1999.0123
  • Jennifer W, Meghan D. Red Blood Cell Alloimmunization in the pregnant patient. Transfus Med Rev. 2018;32(4):213–219. doi:10.1016/j.tmrv.2018.07.002
  • Liu KL, Li N, Li BJ, Peng JY, Shu XW, Yu YY. Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women. Chinese J Contemp Pediatr. 2009;11(3):185–187.
  • Gupta A, Mirza S, Khurana S, et al. Enigmatic weak D antigen: an experience in a Tertiary Care Hospital of East Delhi. J Clin Diagn Res. 2016;10(6):EC12–EC15. doi:10.7860/JCDR/2016/16278.7972
  • Samson A, Hajara B, Health P. Prevalence of Rhesus D-negative blood type and the challenges of Rhesus D immunoprophylaxis among obstetric population in Ogbomoso, Southwestern Nigeria. Ann Trop Med Public Health. 2016;9(1):1–5.
  • Okeke T, Ocheni S, Nwagha U, et al. The prevalence of Rhesus negativity among pregnant women in Enugu, Southeast Nigeria. Niger J Clin Pract. 2012;15(4):400–402.
  • Golassa L, Tsegaye A, Erko B, et al. High rhesus (Rh (D)) negative frequency and ethnic-group based ABO blood group distribution in Ethiopia. BMC Res Notes. 2017;10(1):1–5. doi:10.1186/s13104-017-2644-3
  • Pourfathollah A, Oody A, Honarkaran N. Geographical distribution of ABO and Rh (D) blood groups among Iranian blood donors in the year 1361 (1982) as compared with that of the year 1380 (2001). Sci J Iran Blood Transfus Organ. 2004;1(1):11–17.
  • Mbalibulha Y, Natukunda B, Okwi AL, et al. Alloimmunization to Rh Antigen (D, C, E, C, E) among pregnant women attending antenatal care in South Western Uganda. J Blood Med. 2022;Volume 13:747–752. doi:10.2147/JBM.S385737
  • Al-Dughaishi T, Al Harrasi Y, Al-Duhli M, et al. Red cell alloimmunization to Rhesus antigen among pregnant women attending a tertiary care hospital in Oman. Oman Med Journal. 2016;31(1):77. doi:10.5001/omj.2016.15
  • Mbalibulha Y, Muwanguzi E, Mugyenyi GR, et al. Occurrence of anti-D alloantibodies among pregnant women in Kasese District, Western Uganda. J Blood Med;2015. 125–129. doi:10.2147/JBM.S80977
  • Koelewijn J, de Haas M, Vrijkotte T, et al. Gynaecology. Risk factors for RhD immunisation despite antenatal and postnatal anti‐D prophylaxis. Int J Obstetr Gynaecol. 2009;116(10):1307–1314. doi:10.1111/j.1471-0528.2009.02244.x
  • Filbey D, Hanson U, Wesström G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden. AGOS. 1995;74(9):687–692.
  • Sarhan MA, Saleh KA, Bin-Dajem S. Distribution of ABO blood groups and rhesus factor in Southwest Saudi Arabia. Saudi Med J. 2009;30(1):116–119.
  • Nair SP, Segni H, Kassim M. Maternal alloantibodies and foetal complications in Jimma specialized hospital, South-Western Ethiopia. World J Pharm Res. 2016;5(2):1130–1140.